Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60

被引：0
|
作者：
Foong, Yi Chao [1 ]
Merlo, Daniel [2 ]
Gresle, Melissa [2 ]
Zhu, Chao [2 ]
Buzzard, Katherine [2 ]
Zhong, Michael [1 ]
Yeh, Wei [1 ]
Jokubaitis, Vilija [1 ]
Butzkueven, Helmut [1 ]
van der Walt, Anneke [1 ]
机构：
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Clayton, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 04期
关键词：
ocrelizumab; multiple sclerosis; elderly; comparative efficacy; MSBase;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [41] Monitoring Glatiramer Acetate treatment in multiple sclerosis
    Farina, C
    Hohlfeld, R
    NEUROLOGY, 2002, 58 (07) : A246 - A246
  • [42] The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment
    Messina, Silvia
    Patti, Francesco
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (10) : 1349 - 1359
  • [43] Economic impact of glatiramer acetate in multiple sclerosis
    Ollendorf, DA
    Jilinskaia, E
    Oleen-Burkey, M
    VALUE IN HEALTH, 2002, 5 (06) : 510 - 511
  • [44] Glatiramer acetate: Mechanisms of action in multiple sclerosis
    Schrempf, Wiebke
    Ziemssen, Tjalf
    AUTOIMMUNITY REVIEWS, 2007, 6 (07) : 469 - 475
  • [45] Lipoatrophy in patients with multiple sclerosis on glatiramer acetate
    Edgar, CM
    Brunet, DG
    Fenton, P
    McBride, EV
    Green, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2004, 31 (01) : 58 - 63
  • [46] Glatiramer acetate therapy for multiple sclerosis: a review
    Perumal, Jai
    Filippi, Massimo
    Ford, Corey
    Johnson, Kenneth
    Lisak, Robert
    Metz, Luanne
    Tselis, Alexandros
    Tullman, Mark
    Khan, Omar
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (06) : 1019 - 1029
  • [47] Mechanisms of action of glatiramer acetate in multiple sclerosis
    Neuhaus, O
    Farina, C
    Wekerle, H
    Hohlfeld, R
    NEUROLOGY, 2001, 56 (06) : 702 - 708
  • [48] Comparing the effect of glatiramer acetate 20 mg vs glatiramer acetate 40 mg on retinal structures in patients with relapsing remitting multiple sclerosis
    Gilroy, M.
    Darling, R.
    Lichtman-Mikol, S.
    Razmjou, S.
    Probst-Simmons, E.
    Santiago-Martinez, C.
    Bernitsas, E.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 647 - 648
  • [49] Multiple sclerosis Glatiramer acetate - have the CIS and also for young people make sense
    Oetzel, Stefan
    PSYCHOPHARMAKOTHERAPIE, 2009, 16 (03): : 138 - 139
  • [50] The Effect of Methylprednisolone, Interferon beta and Glatiramer Acetate Treatment on Circulating Adipokines in Multiple Sclerosis Patients
    Michalak, Slawomir
    Jernas, Lukasz
    Tokarz-Kupczyk, Elzbieta
    Wygladalska-Jernas, Halina
    Kozubski, Wojciech
    NEUROLOGY, 2011, 76 (09) : A598 - A599
12345